Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zogenix Inc (NQ: ZGNX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 26.68 (8)
Ask (Size) 26.79 (5)
Prev. Close 26.68
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 56,228,303
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga

Performance

More News

Read More
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Via Benzinga
Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust
Via Benzinga
Recap: Zogenix Q4 Earnings
Via Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
Via Investor's Business Daily
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Via Talk Markets
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Via Benzinga
Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge
Via Benzinga
SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today
Via InvestorPlace
52 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher
Via Benzinga
Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX
From Halper Sadeh LLP
Via Business Wire
GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today
Via InvestorPlace
35 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
Via InvestorPlace
Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit
Via Benzinga
Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest
Via Investor's Business Daily
Why Zogenix Shares Are Soaring Today
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
Via Benzinga
61 Biggest Movers From Yesterday
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.